Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00586-020-06355-1 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Acknowledgments to reviewers of "International Journal of Occupational Medicine and Environmental Health" in 2024.
Int J Occup Med Environ Health
January 2025
Contributors to the Pioneering Investigators collection 2024: Part 3.
Chem Commun (Camb)
January 2025
Editorial: Methods in respiratory pharmacology 2023.
Front Pharmacol
January 2025
Department of Clinical Pharmacology and Therapeutics, Faculty of Medicine and Surgery, University of Malta, Msida, Malta.
Background: Rearranged during transfection () fusions represent a distinct molecular subset of non-small cell lung cancer (NSCLC) with targeted therapeutic potential. Selpercatinib, a highly selective inhibitor, has demonstrated efficacy in various solid tumors harboring alterations. Here, we present a case highlighting the use and clinical outcomes of selpercatinib in a patient diagnosed with advanced lung adenocarcinoma harboring a fusion.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!